2-(3,4-dihydro-5H-spiro[1,5-benzoxazepine-2,4'-piperidin]-5-yl)ethanol | 1298034-51-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 2-(3,4-dihydro-5H-spiro[1,5-benzoxazepine-2,4'-piperidin]-5-yl)ethanol
• 英文别名: 2-Spiro[3,4-dihydro-1,5-benzoxazepine-2,4'-piperidine]-5-ylethanol
• CAS: 1298034-51-1
• 化学式: C₁₅H₂₂N₂O₂
• 分子量: 262.352
• InChiKey: DWOQHSDPUVUBLO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  44.7
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6-chloropyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide 、 2-(3,4-dihydro-5H-spiro[1,5-benzoxazepine-2,4'-piperidin]-5-yl)ethanol 在 三乙胺 作用下， 以 正丁醇 为溶剂， 反应 48.0h， 以54%的产率得到6-[5-(2-hydroxyethyl)-4,5-dihydro-1'H,3H-spiro[1,5-benzoxazepine-2,4'-piperidin]-1'-yl]-N-(2-hydroxy-2-(pyridin-3-yl)ethyl)pyridazine-3-carboxamide
  参考文献：
  名称：

  Discovery of novel SCD1 inhibitors: 5-Alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4′-piperidine] analogs

  摘要：

  Expansion of the 6-membered ring and subsequent fine-tuning of the newly obtained 7-membered spiropiperidine structure resulted in the discovery of a series of novel and potent SCD1 inhibitors. Preliminary SAR was explored by modifying an alkyl chain on the azepine nitrogen and resulted in the identification of a highly potent SCD1 inhibitor: 6-[5-(cyclopropylmethyl)-4,5-dihydro-1'H,3H-spiro[1,5-benzoxazepine-2,4'-piperidin]-1'-yl]-N-(2-hydroxy-2-pyridin-3-ylethyl)pyridazine-3-carboxamide (9). Compound 9 exhibited an IC50 value of 0.01 mu M against human SCD1. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.02.002
• 作为产物：
  描述：

  2-(1'-benzyl-3,4-dihydro-5H-spiro[1,5-benzoxazepine-2,4'-piperidin]-5-yl)ethanol 在 盐酸 、 5% Pd(II)/C(eggshell) 、 氢气 作用下， 以 甲醇 为溶剂， 反应 7.0h， 以57%的产率得到2-(3,4-dihydro-5H-spiro[1,5-benzoxazepine-2,4'-piperidin]-5-yl)ethanol
  参考文献：
  名称：

  Discovery of novel SCD1 inhibitors: 5-Alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4′-piperidine] analogs

  摘要：

  Expansion of the 6-membered ring and subsequent fine-tuning of the newly obtained 7-membered spiropiperidine structure resulted in the discovery of a series of novel and potent SCD1 inhibitors. Preliminary SAR was explored by modifying an alkyl chain on the azepine nitrogen and resulted in the identification of a highly potent SCD1 inhibitor: 6-[5-(cyclopropylmethyl)-4,5-dihydro-1'H,3H-spiro[1,5-benzoxazepine-2,4'-piperidin]-1'-yl]-N-(2-hydroxy-2-pyridin-3-ylethyl)pyridazine-3-carboxamide (9). Compound 9 exhibited an IC50 value of 0.01 mu M against human SCD1. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.02.002